Download presentation
Presentation is loading. Please wait.
1
Diastolic Heart Failure
Diagnosis and Treatment Paul J. Kovack, DO, FACOI, FACC
2
Disclosure I have no conflict of interest for this presentation
3
Outline Background Definition and Diagnostic Criteria Etiology
Pathophysiology Clinical Diagnosis Management
4
Backround CHF affects 5 million Americans
400,000 new cases & 800,000 hospitalizations annually CHF : primarily a disorder of the elderly Among the elderly, it is the most frequent hospital discharge Over 10 billion health care dollars
5
Backround Among the elderly, cardiovascular disease is the MOST common cause of mortality and morbidity. In 1900, 4% of population was over 65. Now 30% 10,000 people turn 65 every day In the US currently, 5 million people have CHF. ½ these cases are from CHF with preserved LV function.
6
Mortality SHF vs DHF
7
DHF more likely to die from non-CV cause
8
Definition Diastolic dysfunction is not the same as Diastolic CHF
Diastolic dysfunction characterizes abnormal relaxation of the LV. It is essentially an echo finding. Diastolic CHF describes a clinical syndrome of CHF in patient with preserved LV function. Diastolic heart failure (DHF) or HFpEF
9
Diagnostic Criteria For diastolic dysfunction, this relies on echo criteria Multiple factors enter into the equation Most are related to aging and hypertension
12
Normal diastolic function
Occupies about 2/3 of the cardiac cycle. Takes longer than systole Active process, requires energy Abnormalities of diastolic function ALWAYS precede those of systolic function. So patients with systolic dysfunction always have diastolic dysfunction
13
CHF is a Clinical Diagnosis
Patient has dyspnea with risk factors such as hypertension, diabetes, ischemia, elderly Subjective signs such as orthopnea and PND Clinical exam shows signs of HF , S4. CXR confirms pulmonary congestion with a normal sized cardiac silhouette ECG may show LVH, Atrial fibrillation. BNP elevated
14
BNP is lower in DHF 1/3 that of SHF Can be normal
15
BNP is lower in DHF
18
Systolic vs Diastolic Congestive heart failure
Exertional Dyspnea Paroxysmal Nocturnal Dyspnea Orthopnea Jugular Venous Distinction Lung Crackles Displaced Aprical Impulse S4 S3 Systolic Heart Failure Diastolic Heart Failure Adapted from Echeverria et al, 1983
19
Is it systolic heat failure or is it diastolic heart failure?
Physical exam CXR BNP Need to look at echo
20
Normal Diastolic filling
1. Isovolumic Relaxation 2. Early rapid diastolic filling phase 3. Diastasis 4. Late diastolic filling due to atrial contraction Quinones, ASE Review 2007
21
Normal Diastolic function
When LV pressure becomes less than LA pressure, MV opens Rapid early diastolic filling begins. Driving force is predominantly elastic recoil and normal relaxation. ~80% LV filling during this phase
22
Normal Diastolic function
As a result of rapid filling, LV pressure rapidly equilibrates with and may exceed LA pressure. Results in deceleration of MV inflow. Late diastolic filling is from atrial contraction. It’s ~ 20% LV filling.
23
MV inflow Patterns 5 stages – Normal and Stages I – IV diastolic dysfunction Stage I – Impaired relaxation Stage II – Pseudo-normal Stage III – Restrictive Filling, reversible Stage IV – Restrictive Filling, irreversible
24
MV PW inflow patterns
25
Stage I
26
Stage I
27
Stage II, Pseudonormal
28
Stage II
29
Stage II Valsalva ➔➔➔
30
Stage III
31
Stage III
32
Diastolic Dysfunction
Grade 1 Grade 2 Grade 3 Grade 4 LV pressure E Mitral flow Tissue Doppler e’ Pulmonary vein Using these Doppler variables, we can grade diastolic dysfunction as we grade heart failure symptoms using NYHA classification. This grading system was proposed by Dr. Tajik of our institution and corrleates well with degree of diastolic dysfunction, filling pressure, and naturally patient’s prognosis. Grade 1 diastolic dysfunction represents mild dysfunction with impaired myocardial relaxation, but filling pressure is normal. In this situation, as long as diastolic filling period is well preserved, patient does not experience significant symptoms. Grade 2 diastolic dysfunction is same as pseudonormalized filling pattern with mild to moderate elevation of filling pressure. Grade 3 and 4 diastolic dysfunction represents most advanced stage, called restrictive pattern, with marked elevation of filling pressure and decreased LV operating compliance. The difference between grade 3 and 4 is reversibility of restrictive diastolic filling. It is important to remember that myocardial relaxation is impaired in all stages of diastolic dysfunction so that (Click) mitral annulus E’ velocity is decreased and mitral flow propagation velocity is reduced. E/e’ < 10 10 -15 >15 >15 CP
33
As LV filling pressure ↑
45 40 35 30 25 20 15 10 5 E/e’ PCWP (mm Hg) r = 0.87 n = 60 As LV filling pressure ↑ Mitral E Annulus e Therefore, as LV filling pressure increases, mitral inflow E velocity increases, but mitral annulus E’ velocity decreases. As a result, E/E’ ratio increases. According to the investigations from Baylor and our institution by Dr. Steve Ommen, E/E’ ratio of 15 or greater usually indicates PCWP 20 mmHg or higher. E/e Nagueh et al: JACC, 1997 Ommen et al: Circ, 2000
34
E/E’ is a robust clinical marker
What the ratio means? > 15 elevated filling pressures < 8 Nl 8 – 15 ??? Nagueh et al, JACC 1997; 30:
35
Etiology
36
Causes of Diastolic dysfunction Heart Failure
Hypertension Obesity Sleep apnea Atrial fibrillation
37
Other Causes Cardiomyopathy CAD Valvular heart disease Diabetes
Hypertrophic Restrictive, Infiltrative, eg Amyloid CAD Valvular heart disease Diabetes Obesity Sleep Apnea Constrictive pericarditis
38
Pathophysiology An inability to increase stroke volume by Frank-Starling mechanism despite severely increased LV filling pressure is indicative of diastolic dysfunction Impairment of ventricular relaxation and decreased compliance of the left ventricle. With mild dysfunction, the ventricle can compensate with an increase in the late filling phase until the end- diastolic volume returns to normal. In severe cases, the ventricle is so stiff that the left atrium fails, and the end-diastolic volume cannot be normalized. This leads to reduced stroke volume and cardiac output.
39
DHF is an important cause of pulmonary hypertension
40
Group 2 Pulmonary hypertension includes SFH, valvular heart disease and DHF
41
Management Primary prevention Smoking cessation
Aggressive control of hypertension, hyperlipidemia and CAD including revascularization Weight loss Limiting alcohol intake Diastolic dysfunction can be present for many years before it is clinically evident Early diagnosis and treatment prevents irreversible structural abnormalities and systolic dysfunction
42
Alcohol and atrial fibrillation
J Am Coll Cardiol 2016;68:
45
TOPCAT trial
46
DIG Trial – HFpEF cohort
No effect on mortality Fewer HF hospitalizations with dig More ACS hospitalizations with dig
47
Beta blockers in DHF: Very little data
49
Taylor, International Journal of Cardiology 2012 Effects of exercise training for heart failure with preserved EF
50
Heart failure is covered for rehab
Only if it is due to systolic dysfunction
51
Interatrial shunt device for HFpEF Outcomes at 1 year
Device implanted in 64 patients to allow small amount of left to right shunting to reduce elevated left atrial pressure Improvemant in 6 minute walk test Improvement in NYHA class Improvement in HF quality of life scores REDUCE LAP-HF Circulation 2016 Nov 16; doi
52
Guideline driven treatment of DHF
ACC/AHA guidelines 2005 similar to 2001 2009 similar to 2005 2013 similar to 2009 2016 is pharmacologic update to now include ARNI. No new information regarding DHF
53
Class I indications
54
ACC/AHA Guidelines 2009 (and 2013) Class IIa
Coronary revascularization if ischemia is thought to be causing diastolic dysfunction
56
ACE/ARB/BB/CaB in DHF Use if you have another indication
Hypertension Diabetes CAD A fib If you have to choose between diuretic and ACE/ARB/BB/CaB Choose diuretic is there is congestion
57
Conclusions There has been a steady rise in prevalence of CHF with preserved LV function. By the 7th decade, incidence of diastolic CHF = systolic CHF By the 8th decade, incidence of diastolic CHF > systolic CHF The survival of patients with the clinical syndrome of heart failure is similar in those with preserved versus those with a reduced LV ejection fraction
58
Conclusions Recognize (amyloid, constriction, restriction)
An important component of Group 2 PHT Treatment: Remove iatrogenic agents (eg NSAIDS) Diuretics BP control HR control Ischemia. Dyspnea as angina equivalent Rhythm control in A fib if still symptomatic with rate control
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.